◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
兰卫医学 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
+Revenue 1.7B 1.7B 4.2B 1.8B 1.2B 1.2B 1.1B 923.0M 805.0M 608.0M 541.0M 463.0M
Revenue Growth % 4.1% -60.1% 136.2% 43.6% 7.4% 9.5% 14.1% 14.7% 32.4% 12.4% 16.8% --
Total Revenue 1.7B 1.7B 4.2B 1.8B 1.2B 1.2B 1.1B 923.0M 805.0M 608.0M 541.0M 463.0M
Cost Of Revenue 1.4B 1.3B 2.4B 1.1B 838.0M 805.0M 728.0M 644.0M 535.0M 395.0M 374.0M 290.0M
+Gross Profit 385.0M 348.0M 1.8B 680.0M 400.0M 348.0M 325.0M 279.0M 270.0M 213.0M 167.0M 173.0M
Gross Margin % 22.1% 20.8% 42.6% 38.2% 32.3% 30.2% 30.9% 30.2% 33.5% 35.0% 30.9% 37.4%
Total Operating Cost 1.8B 1.8B 3.3B 1.5B 1.1B 1.0B 965.0M 932.0M 724.0M 505.0M 453.0M 352.0M
Selling Expenses 88.9M 98.7M 184.0M 125.0M 79.4M 86.5M 78.0M 137.0M 62.9M 31.3M 22.9M 19.9M
Admin Expenses 215.0M 203.0M 356.0M 194.0M 120.0M 115.0M 119.0M 119.0M 113.0M 62.5M 42.7M 37.0M
Rd Expenses 60.0M 48.9M 109.0M 39.4M 21.8M 18.8M 16.9M 13.8M -- -- -- --
Finance Expenses 5.8M 3.4M 7.6M 1.1M -703,800 489,500 4.2M 3.6M 9.4M 9.4M 8.2M 1.2M
+Operating Income -69.3M -136.0M 949.0M 319.0M 178.0M 131.0M 107.0M 7.1M 81.1M 104.0M 87.9M 111.0M
Operating Margin % -4.0% -8.1% 22.6% 17.9% 14.4% 11.4% 10.2% 0.8% 10.1% 17.1% 16.2% 24.0%
Non Operating Income 1.5M 589,900 1.6M 2.0M 559,400 2.2M 83,800 138,300 7.3M 7.5M 1.5M 127,100
Non Operating Expenses 35.0M 18.0M 46.4M 2.9M 16.7M 6.5M 1.1M 1.7M 1.1M 1.3M 106,200 31,200
Investment Income 4.4M -2.1M 748,100 6.2M 6.9M 8.0M 14.5M 4.7M 0.00 0.00 -- --
Fair Value Change Income -- -- 1.7M 3.9M 525,800 1.9M -- -- -- -- -- --
Asset Disposal Income 5.7M 1.9M -363,200 1.0M 652,500 -66,400 -5.6M -461,500 -- -- -- --
Asset Impairment Loss 79.0M 28.9M 136.0M 7.0M 4.6M 1.9M 13.7M 9.4M -42,700 3.4M 3.7M 1.9M
Other Income 15.9M 33.3M 9.9M 14.1M 12.8M 14.7M 9.8M 11.3M -- -- -- --
Income Before Tax -103.0M -153.0M 904.0M 318.0M 162.0M 126.0M 106.0M 5.6M 87.3M 110.0M 89.3M 111.0M
Income Tax -4.2M 8.5M 165.0M 56.4M 27.8M 31.7M 31.7M 25.8M 27.1M 27.7M 18.9M 26.6M
+Net Income -98.6M -162.0M 739.0M 262.0M 134.0M 94.6M 73.9M -20.2M 60.2M 82.3M 70.3M 84.3M
Net Margin % -5.7% -9.7% 17.6% 14.7% 10.8% 8.2% 7.0% -2.2% 7.5% 13.5% 13.0% 18.2%
Net Income Attributable -109.0M -142.0M 617.0M 204.0M 110.0M 92.2M 73.4M 6.4M 58.8M 82.3M 70.3M 84.3M
Minority Interest 10.8M -20.1M 122.0M 57.8M 24.1M 2.4M 548,400 -26.6M 1.4M -- -- --
Eps Basic -0.27 -0.35 1.54 0.58 0.31 0.26 0.21 0.02 0.62 0.92 1.77 2.35
Eps Diluted -0.27 -0.35 1.54 0.58 0.31 0.26 0.21 0.02 -- -- -- --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash And Equivalents 829.0M 861.0M 666.0M 352.0M 412.0M 258.0M 205.0M 140.0M 240.0M 55.4M 36.8M 52.2M
Trading Financial Assets -- -- -- 421.0M 121.0M 228.0M -- -- -- -- -- --
Accounts Receivable 787.0M 1.0B 2.2B 794.0M 516.0M 448.0M 396.0M 369.0M 326.0M 282.0M 180.0M 128.0M
Notes Receivable 2.6M 1.9M 26.0M 25.3M 24.2M 20.9M 24.7M 20.2M 15.7M 3.4M 4.1M --
Notes And Accounts Receivable 789.0M 1.0B 2.2B 820.0M 540.0M 469.0M 420.0M 389.0M 341.0M 285.0M 184.0M 128.0M
Prepayments 4.8M 10.1M 15.6M 15.9M 16.8M 15.0M 8.1M 8.6M 40.8M 29.0M 22.9M 12.5M
Inventory 306.0M 368.0M 402.0M 139.0M 147.0M 174.0M 178.0M 192.0M 120.0M 114.0M 122.0M 79.8M
Total Current Assets 2.0B 2.3B 3.4B 1.8B 1.3B 1.2B 1.2B 1.0B 755.0M 489.0M 416.0M 295.0M
Long Term Equity Investment 1.8M 14.1M 16.4M -- -- -- -- -- -- -- -- --
Fixed Assets -- 469.0M 161.0M 161.0M 117.0M 133.0M 161.0M 159.0M 95.5M 47.8M 31.5M 28.8M
Fixed Assets Total 451.0M 469.0M 161.0M 161.0M 117.0M 133.0M 161.0M 159.0M 95.5M 47.8M 31.5M 28.8M
Construction In Progress -- 9.5M -- 17.0M -- -- 1.4M 10.1M 13.8M -- -- --
Construction In Progress Total 991,800 9.5M -- 17.0M -- -- 1.4M 10.1M 13.8M -- -- --
Intangible Assets 24.5M 26.5M 13.1M 14.8M 12.9M 11.0M 22.4M 20.4M 9.8M 2.2M 2.2M 1.4M
Long Term Deferred Expenses 30.0M 37.2M 49.6M 32.1M 36.1M 40.2M 46.0M 41.6M 12.2M 9.0M 1.4M 1.7M
Total Non Current Assets 625.0M 660.0M 358.0M 338.0M 219.0M 228.0M 286.0M 297.0M 189.0M 76.3M 47.4M 34.7M
Total Assets 2.6B 3.0B 3.7B 2.1B 1.5B 1.4B 1.4B 1.3B 944.0M 566.0M 463.0M 329.0M
Short Term Borrowings 95.1M 182.0M 149.0M 2.0M -- -- 30.0M 70.0M 75.3M 26.3M 20.0M 25.0M
Accounts Payable 389.0M 502.0M 753.0M 253.0M 125.0M 105.0M 160.0M 91.4M 87.4M 56.3M 45.0M 52.9M
Advance Receipts -- -- -- -- -- 11.1M 7.9M 10.5M 18.8M 10.7M 22.8M 24.6M
Contract Liabilities 15.1M 6.6M 28.7M 9.3M 18.5M -- -- -- -- -- -- --
Total Current Liabilities 616.0M 823.0M 1.4B 413.0M 218.0M 179.0M 257.0M 221.0M 329.0M 261.0M 259.0M 199.0M
Long Term Borrowings 134.0M 146.0M -- -- -- -- -- -- -- -- -- --
Total Non Current Liabilities 187.0M 184.0M 60.3M 52.7M 6.1M 7.3M 4.9M 5.0M 3.1M 2.8M 2.9M --
Total Liabilities 803.0M 1.0B 1.5B 466.0M 224.0M 186.0M 262.0M 226.0M 332.0M 263.0M 262.0M 199.0M
Paid In Capital 401.0M 401.0M 401.0M 401.0M 352.0M 352.0M 352.0M 352.0M 98.5M 89.0M 39.7M 39.7M
Capital Reserve 554.0M 554.0M 554.0M 553.0M 462.0M 495.0M 495.0M 495.0M 209.0M 1.2M 7.8M 7.8M
Surplus Reserve 86.5M 86.5M 86.5M 37.8M 22.1M 15.7M 12.1M 4.0M 3.3M 735,500 1.7M 766,400
Retained Earnings 641.0M 750.0M 1.0B 574.0M 386.0M 317.0M 292.0M 227.0M 268.0M 212.0M 152.0M 82.5M
Minority Equity 162.0M 200.0M 209.0M 74.9M 25.1M 32.4M 29.1M 25.8M 33.0M -- -- --
Equity Attributable 1.7B 1.8B 2.1B 1.6B 1.2B 1.2B 1.2B 1.1B 579.0M 302.0M 201.0M 131.0M
Total Equity 1.8B 2.0B 2.3B 1.6B 1.2B 1.2B 1.2B 1.1B 612.0M 302.0M 201.0M 131.0M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash From Sales 2.1B 2.9B 2.8B 1.4B 1.2B 1.2B 1.1B 945.0M 885.0M 587.0M 575.0M 462.0M
Tax Refunds Received 5.9M -- -- -- -- -- -- -- -- -- 5,600 --
Total Operating Cash Inflow 2.1B 2.9B 2.9B 1.4B 1.3B 1.2B 1.1B 960.0M 896.0M 682.0M 629.0M 518.0M
Cash Paid For Goods 1.4B 1.6B 1.8B 700.0M 754.0M 850.0M 665.0M 726.0M 586.0M 380.0M 492.0M 373.0M
Cash Paid To Employees 274.0M 462.0M 564.0M 247.0M 173.0M 148.0M 132.0M 136.0M 97.5M 49.1M 46.2M 28.3M
Taxes Paid 54.3M 121.0M 194.0M 77.2M 64.4M 74.0M 69.4M 45.0M 70.8M 89.4M 42.6M 19.1M
Total Operating Cash Outflow 1.9B 2.4B 2.8B 1.2B 1.1B 1.2B 953.0M 1.1B 869.0M 602.0M 712.0M 516.0M
Operating Cash Flow 216.0M 547.0M 84.2M 224.0M 168.0M 70.6M 185.0M -95.5M 27.1M 79.7M -82.8M 1.6M
Total Investing Cash Inflow 240.0M 252.0M 715.0M 656.0M 568.0M 719.0M 1.4B 672.0M 2.8M 3.0M 0.00 89,200
Total Investing Cash Outflow 309.0M 650.0M 535.0M 1.1B 484.0M 641.0M 1.5B 1.1B 139.0M 47.3M 14.9M 21.6M
Investing Cash Flow -68.6M -398.0M 180.0M -403.0M 83.7M 77.5M -83.6M -429.0M -136.0M -44.3M -14.9M -21.5M
Cash From Borrowings 123.0M 369.0M 198.0M 4.0M -- -- 55.0M 155.0M 130.0M 26.3M 48.0M 25.0M
Dividends And Interest Paid 57.9M 137.0M 126.0M 13.8M 35.3M 66.9M 3.5M 27.8M 9.5M 9.6M 6.8M 1.0M
Debt Repayments 222.0M 169.0M 18.0M 2.0M -- 30.0M 95.0M 159.0M 80.6M 20.0M 53.0M --
Total Financing Cash Inflow 126.0M 378.0M 213.0M 171.0M 2.2M 3.3M 65.3M 624.0M 476.0M 134.0M 172.0M 58.8M
Total Financing Cash Outflow 307.0M 334.0M 163.0M 51.0M 98.3M 99.7M 101.0M 192.0M 190.0M 150.0M 89.8M 1.0M
Financing Cash Flow -180.0M 44.7M 50.5M 120.0M -96.1M -96.4M -35.3M 432.0M 287.0M -16.7M 82.3M 57.8M
Net Change In Cash -32.5M 193.0M 314.0M -60.1M 155.0M 51.2M 65.3M -92.1M 178.0M 18.7M -15.4M 37.9M
Ending Cash Balance 826.0M 858.0M 666.0M 351.0M 412.0M 256.0M 205.0M 140.0M 233.0M 55.4M 36.8M 52.2M
Capex 76.6M 399.0M 230.0M 119.0M 44.5M 39.5M 73.3M 131.0M 103.0M 42.4M 14.9M 16.1M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...